NUTANIX INC - A (NTNX)

US67059N1081 - Common Stock

72.33  +0.47 (+0.65%)

Fundamental Rating

4

Taking everything into account, NTNX scores 4 out of 10 in our fundamental rating. NTNX was compared to 279 industry peers in the Software industry. NTNX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NTNX is quite expensive at the moment. It does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

NTNX had positive earnings in the past year.
NTNX had a positive operating cash flow in the past year.
NTNX had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: NTNX reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of NTNX (-5.82%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 2.25%, NTNX is in the better half of the industry, outperforming 70.61% of the companies in the same industry.
Industry RankSector Rank
ROA -5.82%
ROE N/A
ROIC 2.25%
ROA(3y)-16.56%
ROA(5y)-28.9%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 1.19%, NTNX is in the better half of the industry, outperforming 64.16% of the companies in the same industry.
The Gross Margin of NTNX (84.94%) is better than 92.11% of its industry peers.
In the last couple of years the Gross Margin of NTNX has grown nicely.
Industry RankSector Rank
OM 1.19%
PM (TTM) N/A
GM 84.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.42%
GM growth 5Y2.41%

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NTNX is destroying value.
NTNX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NTNX has been increased compared to 5 years ago.
The debt/assets ratio for NTNX has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.03 indicates that NTNX is not a great score, but indicates only limited risk for bankruptcy at the moment.
NTNX has a Altman-Z score (2.03) which is comparable to the rest of the industry.
NTNX has a debt to FCF ratio of 0.97. This is a very positive value and a sign of high solvency as it would only need 0.97 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 0.97, NTNX is doing good in the industry, outperforming 75.99% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 0.97
Altman-Z 2.03
ROIC/WACC0.21
WACC10.73%

2.3 Liquidity

NTNX has a Current Ratio of 1.19. This is a normal value and indicates that NTNX is financially healthy and should not expect problems in meeting its short term obligations.
NTNX has a worse Current ratio (1.19) than 66.67% of its industry peers.
A Quick Ratio of 1.19 indicates that NTNX should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.19, NTNX is not doing good in the industry: 66.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19

6

3. Growth

3.1 Past

NTNX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 136.36%, which is quite impressive.
The Revenue has grown by 15.35% in the past year. This is quite good.
The Revenue has been growing by 11.69% on average over the past years. This is quite good.
EPS 1Y (TTM)136.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
Revenue 1Y (TTM)15.35%
Revenue growth 3Y15.51%
Revenue growth 5Y11.69%
Sales Q2Q%10.87%

3.2 Future

The Earnings Per Share is expected to grow by 21.97% on average over the next years. This is a very strong growth
Based on estimates for the next years, NTNX will show a quite strong growth in Revenue. The Revenue will grow by 19.39% on average per year.
EPS Next Y12.7%
EPS Next 2Y21.57%
EPS Next 3Y21.97%
EPS Next 5YN/A
Revenue Next Year14.76%
Revenue Next 2Y15.98%
Revenue Next 3Y14.67%
Revenue Next 5Y19.39%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 55.64, which means the current valuation is very expensive for NTNX.
NTNX's Price/Earnings ratio is in line with the industry average.
NTNX is valuated expensively when we compare the Price/Earnings ratio to 29.20, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 49.37, the valuation of NTNX can be described as expensive.
NTNX's Price/Forward Earnings is on the same level as the industry average.
NTNX is valuated expensively when we compare the Price/Forward Earnings ratio to 23.84, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 55.64
Fwd PE 49.37

4.2 Price Multiples

NTNX's Enterprise Value to EBITDA ratio is in line with the industry average.
NTNX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. NTNX is cheaper than 74.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.41
EV/EBITDA 187.25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NTNX does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as NTNX's earnings are expected to grow with 21.97% in the coming years.
PEG (NY)4.38
PEG (5Y)N/A
EPS Next 2Y21.57%
EPS Next 3Y21.97%

0

5. Dividend

5.1 Amount

NTNX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NUTANIX INC - A

NASDAQ:NTNX (11/12/2024, 2:25:04 PM)

72.33

+0.47 (+0.65%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap19.37B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 55.64
Fwd PE 49.37
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)4.38
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.82%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 1.19%
PM (TTM) N/A
GM 84.94%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)136.36%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y12.7%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)15.35%
Revenue growth 3Y15.51%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y